0001144204-14-028971.txt : 20140509
0001144204-14-028971.hdr.sgml : 20140509
20140509143440
ACCESSION NUMBER: 0001144204-14-028971
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140509
DATE AS OF CHANGE: 20140509
EFFECTIVENESS DATE: 20140509
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001137883
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 208133057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-217111
FILM NUMBER: 14828456
BUSINESS ADDRESS:
STREET 1: 605 THIRD AVENUE
STREET 2: 34TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10158
BUSINESS PHONE: 646-666-3188
MAIL ADDRESS:
STREET 1: 605 THIRD AVENUE
STREET 2: 34TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10158
FORMER COMPANY:
FORMER CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 20041122
FORMER COMPANY:
FORMER CONFORMED NAME: GOLDEN HAND RESOURCES INC
DATE OF NAME CHANGE: 20030827
FORMER COMPANY:
FORMER CONFORMED NAME: WIZBANG TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010409
D
1
primary_doc.xml
X0707
D
LIVE
0001137883
BRAINSTORM CELL THERAPEUTICS INC.
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
646-666-3188
DELAWARE
Golden Hand Resources Inc.
BRAINSTORM CELL THERAPEUTICS INC
GOLDEN HAND RESOURCES INC
WIZBANG TECHNOLOGIES INC
Corporation
true
Liat
Sossover
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Executive Officer
Chen
Schor
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Robert
Shorr
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Irit
Arbel
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Alon
Pinkas
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Malcolm
Taub
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Mordechai
Friedman
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Director
Chaim
Lebovits
605 THIRD AVENUE
34TH FLOOR
NEW YORK
NY
NEW YORK
10158
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2014-04-25
false
true
false
0
2470590
1632689
837901
Amounts calculated based on closing share price on April 24, 2014
false
8
0
0
0
false
BRAINSTORM CELL THERAPEUTICS INC.
/s/ Liat Sossover
Liat Sossover
Chief Financial Officer
2014-05-09